نتائج البحث - "Mennitto A."

1

دورية أكاديمية

IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients

المؤلفون: M. Di Salvatore, F. Pietrantonio, A. Orlandi, M. Del Re, R. Berenato, E. Rossi, M. Caporale, D. Guarino, A. Martinetti, M. Basso, R. Mennitto, C. Santonocito, A. Mennitto, G. Schinzari, I. Bossi, E. Capoluongo, R. Danesi, F. de Braud, C. Barone

المساهمون: M. Di Salvatore, F. Pietrantonio, A. Orlandi, M. Del Re, R. Berenato, E. Rossi, M. Caporale, D. Guarino, A. Martinetti, M. Basso, R. Mennitto, C. Santonocito, A. Mennitto, G. Schinzari, I. Bossi, E. Capoluongo, R. Danesi, F. de Braud, C. Barone

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28129643; info:eu-repo/semantics/altIdentifier/wos/WOS:000396024600063; volume:8; issue:10; firstpage:16887; lastpage:16898; numberofpages:12; journal:ONCOTARGET; http://hdl.handle.net/2434/552428Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85014699212

الإتاحة: https://doi.org/10.18632/oncotarget.14810Test
http://hdl.handle.net/2434/552428Test

View record in BASE

2

دورية أكاديمية

GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab : A clinical and translational study

المؤلفون: F. Pietrantonio, C. Maggi, M. Niger, A. Mennitto, F. de Braud, R. Berenato, M. Caporale, M. Milione, F. Perrone, E. Tamborini, D. Baratti, S. Kusamura, L. Mariani, A. Gloghini, I. Bossi, G. Settanni, A. Busico, P. F. Bagnoli, M. Di Bartolomeo, M. Deraco

المساهمون: F. Pietrantonio, R. Berenato, C. Maggi, M. Caporale, M. Milione, F. Perrone, E. Tamborini, D. Baratti, S. Kusamura, L. Mariani, M. Niger, A. Mennitto, A. Gloghini, I. Bossi, G. Settanni, A. Busico, P.F. Bagnoli, M. Di Bartolomeo, M. Deraco, F. de Braud

مصطلحات موضوعية: appendiceal cancer, bevacizumab, GNAS, metronomic capecitabine, next-generation sequencing, peritoneal pseudomyxoma, medicine (all), biochemistry, genetics and molecular biology (all), Settore MED/06 - Oncologia Medica

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/27154293; info:eu-repo/semantics/altIdentifier/wos/WOS:000375475200003; volume:14; issue:1; numberofpages:7; journal:JOURNAL OF TRANSLATIONAL MEDICINE; http://hdl.handle.net/2434/442322Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84965062428

الإتاحة: https://doi.org/10.1186/s12967-016-0877-xTest
http://hdl.handle.net/2434/442322Test

View record in BASE

3

دورية أكاديمية

IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients

المؤلفون: Di Salvatore, Mariantonietta, Pietrantonio, Filippo, Orlandi, Armando, DEL RE, MARZIA, Berenato, Rosa, Rossi, Ernesto, Caporale, Marta, Guarino, Donatella, Martinetti, Antonia, Basso, Michele, Mennitto, Roberta, Santonocito, Concetta, Mennitto, Alessia, Schinzari, Giovanni, Bossi, Ilaria, Capoluongo, Ettore, Danesi, Romano, de Braud, Filippo, Barone, Carlo

المساهمون: Di Salvatore, Mariantonietta, Pietrantonio, Filippo, Orlandi, Armando, DEL RE, Marzia, Berenato, Rosa, Rossi, Ernesto, Caporale, Marta, Guarino, Donatella, Martinetti, Antonia, Basso, Michele, Mennitto, Roberta, Santonocito, Concetta, Mennitto, Alessia, Schinzari, Giovanni, Bossi, Ilaria, Capoluongo, Ettore, Danesi, Romano, de Braud, Filippo, Barone, Carlo

مصطلحات موضوعية: Bevacizumab, Colorectal cancer, ENOS, IL-8, Single nucleotid polymorphism, Oncology

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28129643; info:eu-repo/semantics/altIdentifier/wos/WOS:000396024600063; volume:8; issue:10; firstpage:16887; lastpage:16898; numberofpages:12; journal:ONCOTARGET; http://hdl.handle.net/11568/862961Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85014699212; http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=14810&path%5B%5D=47312Test

الإتاحة: https://doi.org/10.18632/oncotarget.14810Test
http://hdl.handle.net/11568/862961Test
http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=14810&path%5B%5D=47312Test

View record in BASE

4

IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients

المؤلفون: Ettore Capoluongo, Ilaria Bossi, Alessia Mennitto, Concetta Santonocito, Filippo de Braud, Romano Danesi, Roberta Mennitto, Rosa Berenato, Giovanni Schinzari, Ernesto Rossi, Carlo Barone, Donatella Guarino, Mariantonietta Di Salvatore, Marzia Del Re, Marta Caporale, Filippo Pietrantonio, Michele Basso, Antonia Martinetti, Armando Orlandi

المساهمون: Di Salvatore, M, Pietrantonio, F, Orlandi, A, Del Re, M, Berenato, R, Rossi, E, Caporale, M, Guarino, D, Martinetti, A, Basso, M, Mennitto, R, Santonocito, C, Mennitto, A, Schinzari, G, Bossi, I, Capoluongo, E, Danesi, R, de Braud, F, Barone, C

المصدر: Oncotarget

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Pathology, Organoplatinum Compounds, Colorectal cancer, medicine.medical_treatment, Leucovorin, Angiogenesis Inhibitors, law.invention, Cohort Studies, Single nucleotid polymorphism, 0302 clinical medicine, Settore BIO/12 - BIOCHIMICA CLINICA E BIOLOGIA MOLECOLARE CLINICA, law, Enos, Genotype, Antineoplastic Combined Chemotherapy Protocols, Medicine, Neoplasm Metastasis, Clinical pharmacology, biology, ENOS, Treatment Outcome, 030220 oncology & carcinogenesis, Female, Fluorouracil, Colorectal Neoplasms, medicine.drug, Research Paper, medicine.medical_specialty, Bevacizumab, Nitric Oxide Synthase Type III, Single-nucleotide polymorphism, bevacizumab, Polymorphism, Single Nucleotide, 03 medical and health sciences, IL-8, Single nucleotid polymorphisms, Internal medicine, Humans, single nucleotid polymorphisms, Aged, Chemotherapy, business.industry, Interleukin-8, medicine.disease, biology.organism_classification, 030104 developmental biology, Mutation, ras Proteins, business, Pharmacogenetics